Related Experiment Video
Updated: Aug 14, 2026

Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
Microscopic polyangiitis (microscopic polyarteritis) with late emergence of generalised Wegener's granulomatosis
1Internal Medicine Unit, Hospital Casa Maternitat, University of Barcelona, Corporació Sanitària Clínic, Barcelona, Spain.
Objectives:
Recent proposals for the nomenclature of systemic vasculitis have focused on a distinction between (classic) polyarteritis nodosa (PAN) and microscopic polyangiitis or polyarteritis (MPA). Thus, MPA may cause necrotising vasculitis of medium sized or small arteries but, unlike PAN, involvement of "microscopic" vessels must always be present in the former. This study aimed to show that the term "MPA" may represent a source of misinterpretation and to help illustrate difficulties of applying diagnostic criteria/definitions for conditions of unknown aetiology or variable clinical presentation and course.
Methods:
Among 1250 consecutive patients screened for antineutrophil cytoplasmic antibodies (ANCA), 59 had been found to have idiopathic necrotising and crescentic glomerulonephritis plus ANCA while five had been found to have isolated pulmonary haemorrhage with biopsy verified necrotising alveolar capillaritis plus ANCA. None of these patients had clinical or histological evidence of Wegener's granulomatosis (WG) or evidence of biopsy verified vasculitis involving vessels other than glomerular or pulmonary capillaries at the time of presentation.
Results:
Six of the 64 patients who met definition criteria for MPA at the time of initial diagnoses had entered into complete clinical remission upon appropriate corticosteroid and cyclophosphamide treatment between two weeks and three months, though subsequently (20 to 72 months; mean time: 42.3 months) developed characteristic clinical and histological features of overt WG.
Conclusions:
Microscopic polyangiitis/polyarteritis may be a dynamic condition with clinical and histopathological features evolving over time to other forms of small vessel vasculitis, mainly WG, thereby meaning that follow up would be necessary not only to control a given patient but also to make a final diagnosis. This follow up should be for a long time as there may be a long interval between initial presentation and subsequent development of WG lesions.
Insights
Microscopic polyangiitis (MPA) can evolve into Wegener's granulomatosis (WG), highlighting the need for long-term follow-up for accurate diagnosis of systemic vasculitis. This evolution underscores the dynamic nature of these conditions.
Area of Science:
- Rheumatology
- Nephrology
- Immunology
Background:
- Recent nomenclature distinguishes polyarteritis nodosa (PAN) from microscopic polyangiitis (MPA).
- MPA involves necrotizing vasculitis of small or medium arteries with "microscopic" vessel involvement.
- The term MPA may cause misinterpretation due to variable presentations.
Purpose of the Study:
- To demonstrate that "MPA" can be a misnomer.
- To illustrate diagnostic challenges in vasculitis with unknown etiology or variable course.
- To highlight the dynamic nature of MPA.
Main Methods:
- Screened 1250 patients for antineutrophil cytoplasmic antibodies (ANCA).
- Identified 64 patients with ANCA-associated glomerulonephritis or pulmonary hemorrhage without Wegener's granulomatosis (WG) at presentation.
- None had evidence of vasculitis beyond capillaries initially.
Main Results:
- Six of 64 patients initially diagnosed with MPA achieved remission with treatment.
- These six patients later developed overt Wegener's granulomatosis (WG) features.
- Development of WG occurred 20-72 months after initial diagnosis.
Conclusions:
- Microscopic polyangiitis (MPA) can be a dynamic condition.
- MPA may evolve into other small vessel vasculitides, primarily WG.
- Long-term follow-up is crucial for definitive diagnosis and management of evolving vasculitis.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Peripheral Artery Disease I: Introduction
Atypical Pneumonia
Chronic Inflammation: Introduction
Diabetic Nephropathy
Gastritis II: Pathophysiology

